suprathelLogo

INDICATIONS

  Superficial Partial Thickness 

  • Blisters can be present
  • Involvement of the entire epidermis and upperlayers of the dermis layers of the dermis
  • Wound color will be pink or red
  • Painful and appearing wet
  • Wound will blanch when pressure is applied

Partial Thickness & Deep Dermal

Mixed burns of partial thickness and deep dermal,
right hand after an electric burn injury 1 day after
debridement
  • Wound may be red or white in color, appears dry
  • Blister formation may occur
  • Destruction of the entire epidermis and part of the dermis
  • Blanching is sluggish or absent
  • Sensation may be present, but diminished

Case Study 1: Electric Burn

Full Thickness in small areas

Mixed burns of partial thickness and deep dermal and small full thickness,
right hand after an electric burn injury, day of trauma
  • Destruction of the entire epidermis and dermis in areas of near 5 x 6cm
  • Rags of epidermis may prevail
  • Tissue appears white or dark in color after debridement
  • Wound bed without sensation

Case Study 2: Electric Burn

Split skin graft donor site

Extensive skin abrasion

 

Burn-like syndromes

In particular, SUPRATHEL® is successfully used in so called “burn-like syndromes” that describe the wide range of diseases manifested by extensive epidermal blistering and sloughing, as well as cutaneous necrosis requiring hospitalization and special intensive care management. Case Study 3: TEN (Toxic Epidermal Necrolysis) Use of SUPRATHEL® in two paediatric patients with Toxic Epidermal Necrolysis (TEN).

6.1. TEN (toxic epidermal necrolysis)

Skin lesions degree 2a, 80% BSA

TEN (toxic epidermal necrolysis) is described to patients with extensive loss of epidermis due to necrosis and a scalded-looking skin. TEN is the most serious of drug-related skin eruptions with a mortality rate between 11-70%. Patients with less than 10% of epidermal detachment are classified as Stevens-Johnson syndrome, while those with more than 30% of TBSA involvement are classified as TEN.

6.2. EB (Epidermolysis bullosa)

EB (Epidermolysis bullosa). There are a few case reports in using SUPRATHEL®. Major advantage in this indication results in faster wound healing.

SUPRATHEL®-assisted surgical treatment of the hand in epidermolysis bullosa patient Suprathel®-assisted surgical treatment of the hand in a dystrophic epidermolysis bullosa patient

6.3. SSSS (Staphylococcal scalded skin syndrome)

SSSS (Staphylococcal scalded skin syndrome) is caused by infection with certain strains of Staphylococcus bacteria causing skin damage with blisters, as if the skin were scalded.

An innovative local treatment for staphylococcal scalded skin syndrome

6.4. Frostbites

Frostbite is an injury caused by exposure of parts of the body due to freezing.

Treatment of Frostbite: Effectiveness of Suprathel Application

SUPRATHEL® used in combination with

7.1. Autologous grafts

SUPRATHEL® can also be ideally combined with autologous grafts,
e.g. on top of expanded mesh grafts.

7.2. VAC® (Vacuum assisted closure)

SUPRATHEL® may also be applied together with VAC® (Vacuum assisted closure)